nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitomycin—Alkylating Activity—Dacarbazine—pancreatic cancer	0.473	1	CiPCiCtD
Mitomycin—stomach cancer—pancreatic cancer	0.33	1	CtDrD
Mitomycin—POR—Doxorubicin—pancreatic cancer	0.0768	0.561	CbGbCtD
Mitomycin—ABCB1—Tamoxifen—pancreatic cancer	0.012	0.0875	CbGbCtD
Mitomycin—ABCB1—Gemcitabine—pancreatic cancer	0.0103	0.0754	CbGbCtD
Mitomycin—ABCB1—Erlotinib—pancreatic cancer	0.0102	0.0744	CbGbCtD
Mitomycin—ABCB1—Irinotecan—pancreatic cancer	0.0092	0.0672	CbGbCtD
Mitomycin—ABCB1—Docetaxel—pancreatic cancer	0.00674	0.0492	CbGbCtD
Mitomycin—ABCB1—Sunitinib—pancreatic cancer	0.00671	0.049	CbGbCtD
Mitomycin—ABCB1—Doxorubicin—pancreatic cancer	0.00503	0.0367	CbGbCtD
Mitomycin—Stomatitis—Fluorouracil—pancreatic cancer	0.00011	0.00185	CcSEcCtD
Mitomycin—Discomfort—Tamoxifen—pancreatic cancer	0.00011	0.00184	CcSEcCtD
Mitomycin—Oedema—Tamoxifen—pancreatic cancer	0.000107	0.00179	CcSEcCtD
Mitomycin—Oedema—Erlotinib—pancreatic cancer	0.000106	0.00177	CcSEcCtD
Mitomycin—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000104	0.00175	CcSEcCtD
Mitomycin—Extravasation—Doxorubicin—pancreatic cancer	0.000104	0.00175	CcSEcCtD
Mitomycin—Ulcer—Epirubicin—pancreatic cancer	0.000104	0.00174	CcSEcCtD
Mitomycin—Shock—Erlotinib—pancreatic cancer	0.000104	0.00174	CcSEcCtD
Mitomycin—Anaemia—Sunitinib—pancreatic cancer	0.000104	0.00174	CcSEcCtD
Mitomycin—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000103	0.00173	CcSEcCtD
Mitomycin—Anorexia—Tamoxifen—pancreatic cancer	0.000102	0.00171	CcSEcCtD
Mitomycin—Anorexia—Erlotinib—pancreatic cancer	0.000101	0.00169	CcSEcCtD
Mitomycin—Leukopenia—Sunitinib—pancreatic cancer	0.0001	0.00168	CcSEcCtD
Mitomycin—Injection site reaction—Epirubicin—pancreatic cancer	9.78e-05	0.00164	CcSEcCtD
Mitomycin—Cough—Sunitinib—pancreatic cancer	9.77e-05	0.00164	CcSEcCtD
Mitomycin—Hypertension—Sunitinib—pancreatic cancer	9.67e-05	0.00162	CcSEcCtD
Mitomycin—Ulcer—Doxorubicin—pancreatic cancer	9.63e-05	0.00161	CcSEcCtD
Mitomycin—Dyspnoea—Tamoxifen—pancreatic cancer	9.51e-05	0.0016	CcSEcCtD
Mitomycin—Dyspnoea—Erlotinib—pancreatic cancer	9.41e-05	0.00158	CcSEcCtD
Mitomycin—Alopecia—Irinotecan—pancreatic cancer	9.37e-05	0.00157	CcSEcCtD
Mitomycin—Decreased appetite—Tamoxifen—pancreatic cancer	9.28e-05	0.00156	CcSEcCtD
Mitomycin—Fatigue—Tamoxifen—pancreatic cancer	9.2e-05	0.00154	CcSEcCtD
Mitomycin—Decreased appetite—Erlotinib—pancreatic cancer	9.18e-05	0.00154	CcSEcCtD
Mitomycin—Oedema—Sunitinib—pancreatic cancer	9.14e-05	0.00153	CcSEcCtD
Mitomycin—Pain—Tamoxifen—pancreatic cancer	9.13e-05	0.00153	CcSEcCtD
Mitomycin—Alopecia—Gemcitabine—pancreatic cancer	9.12e-05	0.00153	CcSEcCtD
Mitomycin—Fatigue—Erlotinib—pancreatic cancer	9.1e-05	0.00153	CcSEcCtD
Mitomycin—Injection site reaction—Doxorubicin—pancreatic cancer	9.05e-05	0.00152	CcSEcCtD
Mitomycin—Pain—Erlotinib—pancreatic cancer	9.03e-05	0.00151	CcSEcCtD
Mitomycin—Shock—Sunitinib—pancreatic cancer	8.99e-05	0.00151	CcSEcCtD
Mitomycin—Erythema—Gemcitabine—pancreatic cancer	8.99e-05	0.00151	CcSEcCtD
Mitomycin—Alopecia—Fluorouracil—pancreatic cancer	8.97e-05	0.0015	CcSEcCtD
Mitomycin—Thrombocytopenia—Sunitinib—pancreatic cancer	8.95e-05	0.0015	CcSEcCtD
Mitomycin—Erythema—Fluorouracil—pancreatic cancer	8.84e-05	0.00148	CcSEcCtD
Mitomycin—Pulmonary oedema—Epirubicin—pancreatic cancer	8.76e-05	0.00147	CcSEcCtD
Mitomycin—Anorexia—Sunitinib—pancreatic cancer	8.71e-05	0.00146	CcSEcCtD
Mitomycin—Pancytopenia—Docetaxel—pancreatic cancer	8.69e-05	0.00146	CcSEcCtD
Mitomycin—Ill-defined disorder—Irinotecan—pancreatic cancer	8.56e-05	0.00144	CcSEcCtD
Mitomycin—Anaemia—Irinotecan—pancreatic cancer	8.53e-05	0.00143	CcSEcCtD
Mitomycin—Body temperature increased—Erlotinib—pancreatic cancer	8.35e-05	0.0014	CcSEcCtD
Mitomycin—Ill-defined disorder—Gemcitabine—pancreatic cancer	8.34e-05	0.0014	CcSEcCtD
Mitomycin—Vision blurred—Fluorouracil—pancreatic cancer	8.33e-05	0.0014	CcSEcCtD
Mitomycin—Malaise—Irinotecan—pancreatic cancer	8.32e-05	0.0014	CcSEcCtD
Mitomycin—Anaemia—Gemcitabine—pancreatic cancer	8.31e-05	0.00139	CcSEcCtD
Mitomycin—Syncope—Irinotecan—pancreatic cancer	8.27e-05	0.00139	CcSEcCtD
Mitomycin—Leukopenia—Irinotecan—pancreatic cancer	8.26e-05	0.00138	CcSEcCtD
Mitomycin—Thrombophlebitis—Epirubicin—pancreatic cancer	8.25e-05	0.00138	CcSEcCtD
Mitomycin—Anaemia—Fluorouracil—pancreatic cancer	8.17e-05	0.00137	CcSEcCtD
Mitomycin—Dyspnoea—Sunitinib—pancreatic cancer	8.15e-05	0.00137	CcSEcCtD
Mitomycin—Loss of consciousness—Irinotecan—pancreatic cancer	8.11e-05	0.00136	CcSEcCtD
Mitomycin—Malaise—Gemcitabine—pancreatic cancer	8.1e-05	0.00136	CcSEcCtD
Mitomycin—Pulmonary oedema—Doxorubicin—pancreatic cancer	8.1e-05	0.00136	CcSEcCtD
Mitomycin—Cough—Irinotecan—pancreatic cancer	8.05e-05	0.00135	CcSEcCtD
Mitomycin—Leukopenia—Gemcitabine—pancreatic cancer	8.04e-05	0.00135	CcSEcCtD
Mitomycin—Renal failure—Docetaxel—pancreatic cancer	8.02e-05	0.00135	CcSEcCtD
Mitomycin—Hypertension—Irinotecan—pancreatic cancer	7.97e-05	0.00134	CcSEcCtD
Mitomycin—Stomatitis—Docetaxel—pancreatic cancer	7.95e-05	0.00133	CcSEcCtD
Mitomycin—Decreased appetite—Sunitinib—pancreatic cancer	7.95e-05	0.00133	CcSEcCtD
Mitomycin—Leukopenia—Fluorouracil—pancreatic cancer	7.91e-05	0.00133	CcSEcCtD
Mitomycin—Fatigue—Sunitinib—pancreatic cancer	7.88e-05	0.00132	CcSEcCtD
Mitomycin—Cardiac failure congestive—Epirubicin—pancreatic cancer	7.88e-05	0.00132	CcSEcCtD
Mitomycin—Cough—Gemcitabine—pancreatic cancer	7.84e-05	0.00132	CcSEcCtD
Mitomycin—Pain—Sunitinib—pancreatic cancer	7.82e-05	0.00131	CcSEcCtD
Mitomycin—Discomfort—Irinotecan—pancreatic cancer	7.76e-05	0.0013	CcSEcCtD
Mitomycin—Hypertension—Gemcitabine—pancreatic cancer	7.76e-05	0.0013	CcSEcCtD
Mitomycin—Asthenia—Tamoxifen—pancreatic cancer	7.66e-05	0.00128	CcSEcCtD
Mitomycin—Thrombophlebitis—Doxorubicin—pancreatic cancer	7.63e-05	0.00128	CcSEcCtD
Mitomycin—Confusional state—Irinotecan—pancreatic cancer	7.59e-05	0.00127	CcSEcCtD
Mitomycin—Asthenia—Erlotinib—pancreatic cancer	7.58e-05	0.00127	CcSEcCtD
Mitomycin—Discomfort—Gemcitabine—pancreatic cancer	7.56e-05	0.00127	CcSEcCtD
Mitomycin—Oedema—Irinotecan—pancreatic cancer	7.53e-05	0.00126	CcSEcCtD
Mitomycin—Renal impairment—Epirubicin—pancreatic cancer	7.51e-05	0.00126	CcSEcCtD
Mitomycin—Discomfort—Fluorouracil—pancreatic cancer	7.43e-05	0.00125	CcSEcCtD
Mitomycin—Shock—Irinotecan—pancreatic cancer	7.41e-05	0.00124	CcSEcCtD
Mitomycin—Thrombocytopenia—Irinotecan—pancreatic cancer	7.37e-05	0.00124	CcSEcCtD
Mitomycin—Oedema—Gemcitabine—pancreatic cancer	7.33e-05	0.00123	CcSEcCtD
Mitomycin—Diarrhoea—Tamoxifen—pancreatic cancer	7.3e-05	0.00122	CcSEcCtD
Mitomycin—Cardiac failure congestive—Doxorubicin—pancreatic cancer	7.29e-05	0.00122	CcSEcCtD
Mitomycin—Confusional state—Fluorouracil—pancreatic cancer	7.27e-05	0.00122	CcSEcCtD
Mitomycin—Body temperature increased—Sunitinib—pancreatic cancer	7.23e-05	0.00121	CcSEcCtD
Mitomycin—Diarrhoea—Erlotinib—pancreatic cancer	7.22e-05	0.00121	CcSEcCtD
Mitomycin—Oedema—Fluorouracil—pancreatic cancer	7.21e-05	0.00121	CcSEcCtD
Mitomycin—Thrombocytopenia—Gemcitabine—pancreatic cancer	7.18e-05	0.0012	CcSEcCtD
Mitomycin—Anorexia—Irinotecan—pancreatic cancer	7.18e-05	0.0012	CcSEcCtD
Mitomycin—Thrombocytopenia—Fluorouracil—pancreatic cancer	7.06e-05	0.00118	CcSEcCtD
Mitomycin—Dizziness—Tamoxifen—pancreatic cancer	7.06e-05	0.00118	CcSEcCtD
Mitomycin—Anorexia—Gemcitabine—pancreatic cancer	6.99e-05	0.00117	CcSEcCtD
Mitomycin—Dizziness—Erlotinib—pancreatic cancer	6.98e-05	0.00117	CcSEcCtD
Mitomycin—Renal impairment—Doxorubicin—pancreatic cancer	6.94e-05	0.00116	CcSEcCtD
Mitomycin—Anorexia—Fluorouracil—pancreatic cancer	6.87e-05	0.00115	CcSEcCtD
Mitomycin—Vomiting—Tamoxifen—pancreatic cancer	6.79e-05	0.00114	CcSEcCtD
Mitomycin—Rash—Tamoxifen—pancreatic cancer	6.73e-05	0.00113	CcSEcCtD
Mitomycin—Dermatitis—Tamoxifen—pancreatic cancer	6.72e-05	0.00113	CcSEcCtD
Mitomycin—Vomiting—Erlotinib—pancreatic cancer	6.71e-05	0.00113	CcSEcCtD
Mitomycin—Dyspnoea—Irinotecan—pancreatic cancer	6.71e-05	0.00113	CcSEcCtD
Mitomycin—Somnolence—Irinotecan—pancreatic cancer	6.69e-05	0.00112	CcSEcCtD
Mitomycin—Headache—Tamoxifen—pancreatic cancer	6.69e-05	0.00112	CcSEcCtD
Mitomycin—Rash—Erlotinib—pancreatic cancer	6.66e-05	0.00112	CcSEcCtD
Mitomycin—Dermatitis—Erlotinib—pancreatic cancer	6.65e-05	0.00112	CcSEcCtD
Mitomycin—Headache—Erlotinib—pancreatic cancer	6.61e-05	0.00111	CcSEcCtD
Mitomycin—Asthenia—Sunitinib—pancreatic cancer	6.56e-05	0.0011	CcSEcCtD
Mitomycin—Decreased appetite—Irinotecan—pancreatic cancer	6.55e-05	0.0011	CcSEcCtD
Mitomycin—Dyspnoea—Gemcitabine—pancreatic cancer	6.54e-05	0.0011	CcSEcCtD
Mitomycin—Somnolence—Gemcitabine—pancreatic cancer	6.52e-05	0.00109	CcSEcCtD
Mitomycin—Fatigue—Irinotecan—pancreatic cancer	6.49e-05	0.00109	CcSEcCtD
Mitomycin—Alopecia—Docetaxel—pancreatic cancer	6.47e-05	0.00109	CcSEcCtD
Mitomycin—Pain—Irinotecan—pancreatic cancer	6.44e-05	0.00108	CcSEcCtD
Mitomycin—Dyspnoea—Fluorouracil—pancreatic cancer	6.43e-05	0.00108	CcSEcCtD
Mitomycin—Somnolence—Fluorouracil—pancreatic cancer	6.41e-05	0.00108	CcSEcCtD
Mitomycin—Erythema—Docetaxel—pancreatic cancer	6.38e-05	0.00107	CcSEcCtD
Mitomycin—Decreased appetite—Gemcitabine—pancreatic cancer	6.38e-05	0.00107	CcSEcCtD
Mitomycin—Nausea—Tamoxifen—pancreatic cancer	6.34e-05	0.00106	CcSEcCtD
Mitomycin—Fatigue—Gemcitabine—pancreatic cancer	6.32e-05	0.00106	CcSEcCtD
Mitomycin—Pain—Gemcitabine—pancreatic cancer	6.27e-05	0.00105	CcSEcCtD
Mitomycin—Nausea—Erlotinib—pancreatic cancer	6.27e-05	0.00105	CcSEcCtD
Mitomycin—Decreased appetite—Fluorouracil—pancreatic cancer	6.27e-05	0.00105	CcSEcCtD
Mitomycin—Diarrhoea—Sunitinib—pancreatic cancer	6.25e-05	0.00105	CcSEcCtD
Mitomycin—Feeling abnormal—Irinotecan—pancreatic cancer	6.2e-05	0.00104	CcSEcCtD
Mitomycin—Pain—Fluorouracil—pancreatic cancer	6.17e-05	0.00103	CcSEcCtD
Mitomycin—Dizziness—Sunitinib—pancreatic cancer	6.04e-05	0.00101	CcSEcCtD
Mitomycin—Feeling abnormal—Gemcitabine—pancreatic cancer	6.04e-05	0.00101	CcSEcCtD
Mitomycin—Body temperature increased—Irinotecan—pancreatic cancer	5.95e-05	0.000998	CcSEcCtD
Mitomycin—Feeling abnormal—Fluorouracil—pancreatic cancer	5.94e-05	0.000997	CcSEcCtD
Mitomycin—Anaemia—Docetaxel—pancreatic cancer	5.89e-05	0.000989	CcSEcCtD
Mitomycin—Pancytopenia—Epirubicin—pancreatic cancer	5.86e-05	0.000983	CcSEcCtD
Mitomycin—Vomiting—Sunitinib—pancreatic cancer	5.81e-05	0.000975	CcSEcCtD
Mitomycin—Body temperature increased—Gemcitabine—pancreatic cancer	5.8e-05	0.000972	CcSEcCtD
Mitomycin—Rash—Sunitinib—pancreatic cancer	5.76e-05	0.000967	CcSEcCtD
Mitomycin—Dermatitis—Sunitinib—pancreatic cancer	5.76e-05	0.000966	CcSEcCtD
Mitomycin—Headache—Sunitinib—pancreatic cancer	5.73e-05	0.00096	CcSEcCtD
Mitomycin—Syncope—Docetaxel—pancreatic cancer	5.72e-05	0.000959	CcSEcCtD
Mitomycin—Leukopenia—Docetaxel—pancreatic cancer	5.71e-05	0.000957	CcSEcCtD
Mitomycin—Body temperature increased—Fluorouracil—pancreatic cancer	5.7e-05	0.000956	CcSEcCtD
Mitomycin—Loss of consciousness—Docetaxel—pancreatic cancer	5.61e-05	0.00094	CcSEcCtD
Mitomycin—Cough—Docetaxel—pancreatic cancer	5.57e-05	0.000933	CcSEcCtD
Mitomycin—Hypertension—Docetaxel—pancreatic cancer	5.51e-05	0.000923	CcSEcCtD
Mitomycin—Drowsiness—Epirubicin—pancreatic cancer	5.5e-05	0.000923	CcSEcCtD
Mitomycin—Nausea—Sunitinib—pancreatic cancer	5.43e-05	0.000911	CcSEcCtD
Mitomycin—Pancytopenia—Doxorubicin—pancreatic cancer	5.42e-05	0.00091	CcSEcCtD
Mitomycin—Renal failure—Epirubicin—pancreatic cancer	5.41e-05	0.000907	CcSEcCtD
Mitomycin—Asthenia—Irinotecan—pancreatic cancer	5.4e-05	0.000906	CcSEcCtD
Mitomycin—Stomatitis—Epirubicin—pancreatic cancer	5.37e-05	0.0009	CcSEcCtD
Mitomycin—Asthenia—Gemcitabine—pancreatic cancer	5.26e-05	0.000883	CcSEcCtD
Mitomycin—Confusional state—Docetaxel—pancreatic cancer	5.25e-05	0.00088	CcSEcCtD
Mitomycin—Oedema—Docetaxel—pancreatic cancer	5.2e-05	0.000873	CcSEcCtD
Mitomycin—Diarrhoea—Irinotecan—pancreatic cancer	5.15e-05	0.000864	CcSEcCtD
Mitomycin—Shock—Docetaxel—pancreatic cancer	5.12e-05	0.000859	CcSEcCtD
Mitomycin—Thrombocytopenia—Docetaxel—pancreatic cancer	5.1e-05	0.000855	CcSEcCtD
Mitomycin—Drowsiness—Doxorubicin—pancreatic cancer	5.09e-05	0.000854	CcSEcCtD
Mitomycin—Diarrhoea—Gemcitabine—pancreatic cancer	5.02e-05	0.000842	CcSEcCtD
Mitomycin—Renal failure—Doxorubicin—pancreatic cancer	5.01e-05	0.00084	CcSEcCtD
Mitomycin—Dizziness—Irinotecan—pancreatic cancer	4.98e-05	0.000835	CcSEcCtD
Mitomycin—Stomatitis—Doxorubicin—pancreatic cancer	4.96e-05	0.000833	CcSEcCtD
Mitomycin—Anorexia—Docetaxel—pancreatic cancer	4.96e-05	0.000832	CcSEcCtD
Mitomycin—Diarrhoea—Fluorouracil—pancreatic cancer	4.93e-05	0.000827	CcSEcCtD
Mitomycin—Vomiting—Irinotecan—pancreatic cancer	4.79e-05	0.000803	CcSEcCtD
Mitomycin—Dizziness—Fluorouracil—pancreatic cancer	4.77e-05	0.0008	CcSEcCtD
Mitomycin—Rash—Irinotecan—pancreatic cancer	4.75e-05	0.000796	CcSEcCtD
Mitomycin—Dermatitis—Irinotecan—pancreatic cancer	4.74e-05	0.000795	CcSEcCtD
Mitomycin—Headache—Irinotecan—pancreatic cancer	4.72e-05	0.000791	CcSEcCtD
Mitomycin—Vomiting—Gemcitabine—pancreatic cancer	4.66e-05	0.000782	CcSEcCtD
Mitomycin—Dyspnoea—Docetaxel—pancreatic cancer	4.64e-05	0.000778	CcSEcCtD
Mitomycin—Somnolence—Docetaxel—pancreatic cancer	4.63e-05	0.000776	CcSEcCtD
Mitomycin—Rash—Gemcitabine—pancreatic cancer	4.62e-05	0.000776	CcSEcCtD
Mitomycin—Dermatitis—Gemcitabine—pancreatic cancer	4.62e-05	0.000775	CcSEcCtD
Mitomycin—Headache—Gemcitabine—pancreatic cancer	4.59e-05	0.000771	CcSEcCtD
Mitomycin—Vomiting—Fluorouracil—pancreatic cancer	4.59e-05	0.000769	CcSEcCtD
Mitomycin—Rash—Fluorouracil—pancreatic cancer	4.55e-05	0.000763	CcSEcCtD
Mitomycin—Dermatitis—Fluorouracil—pancreatic cancer	4.54e-05	0.000762	CcSEcCtD
Mitomycin—Decreased appetite—Docetaxel—pancreatic cancer	4.52e-05	0.000759	CcSEcCtD
Mitomycin—Headache—Fluorouracil—pancreatic cancer	4.52e-05	0.000758	CcSEcCtD
Mitomycin—Fatigue—Docetaxel—pancreatic cancer	4.49e-05	0.000753	CcSEcCtD
Mitomycin—Nausea—Irinotecan—pancreatic cancer	4.47e-05	0.00075	CcSEcCtD
Mitomycin—Pain—Docetaxel—pancreatic cancer	4.45e-05	0.000746	CcSEcCtD
Mitomycin—Alopecia—Epirubicin—pancreatic cancer	4.37e-05	0.000732	CcSEcCtD
Mitomycin—Nausea—Gemcitabine—pancreatic cancer	4.36e-05	0.000731	CcSEcCtD
Mitomycin—Erythema—Epirubicin—pancreatic cancer	4.3e-05	0.000721	CcSEcCtD
Mitomycin—Feeling abnormal—Docetaxel—pancreatic cancer	4.29e-05	0.000719	CcSEcCtD
Mitomycin—Nausea—Fluorouracil—pancreatic cancer	4.28e-05	0.000718	CcSEcCtD
Mitomycin—Body temperature increased—Docetaxel—pancreatic cancer	4.11e-05	0.00069	CcSEcCtD
Mitomycin—Vision blurred—Epirubicin—pancreatic cancer	4.05e-05	0.00068	CcSEcCtD
Mitomycin—Alopecia—Doxorubicin—pancreatic cancer	4.04e-05	0.000678	CcSEcCtD
Mitomycin—Ill-defined disorder—Epirubicin—pancreatic cancer	3.99e-05	0.000669	CcSEcCtD
Mitomycin—Erythema—Doxorubicin—pancreatic cancer	3.98e-05	0.000667	CcSEcCtD
Mitomycin—Anaemia—Epirubicin—pancreatic cancer	3.98e-05	0.000667	CcSEcCtD
Mitomycin—Malaise—Epirubicin—pancreatic cancer	3.88e-05	0.000651	CcSEcCtD
Mitomycin—Syncope—Epirubicin—pancreatic cancer	3.86e-05	0.000647	CcSEcCtD
Mitomycin—Leukopenia—Epirubicin—pancreatic cancer	3.85e-05	0.000646	CcSEcCtD
Mitomycin—Loss of consciousness—Epirubicin—pancreatic cancer	3.78e-05	0.000634	CcSEcCtD
Mitomycin—Cough—Epirubicin—pancreatic cancer	3.75e-05	0.00063	CcSEcCtD
Mitomycin—Vision blurred—Doxorubicin—pancreatic cancer	3.75e-05	0.000629	CcSEcCtD
Mitomycin—Asthenia—Docetaxel—pancreatic cancer	3.73e-05	0.000626	CcSEcCtD
Mitomycin—Hypertension—Epirubicin—pancreatic cancer	3.71e-05	0.000623	CcSEcCtD
Mitomycin—Ill-defined disorder—Doxorubicin—pancreatic cancer	3.69e-05	0.000619	CcSEcCtD
Mitomycin—Anaemia—Doxorubicin—pancreatic cancer	3.68e-05	0.000617	CcSEcCtD
Mitomycin—Discomfort—Epirubicin—pancreatic cancer	3.62e-05	0.000607	CcSEcCtD
Mitomycin—Malaise—Doxorubicin—pancreatic cancer	3.59e-05	0.000602	CcSEcCtD
Mitomycin—Syncope—Doxorubicin—pancreatic cancer	3.57e-05	0.000599	CcSEcCtD
Mitomycin—Leukopenia—Doxorubicin—pancreatic cancer	3.56e-05	0.000597	CcSEcCtD
Mitomycin—Diarrhoea—Docetaxel—pancreatic cancer	3.56e-05	0.000597	CcSEcCtD
Mitomycin—Confusional state—Epirubicin—pancreatic cancer	3.54e-05	0.000594	CcSEcCtD
Mitomycin—Oedema—Epirubicin—pancreatic cancer	3.51e-05	0.000589	CcSEcCtD
Mitomycin—Loss of consciousness—Doxorubicin—pancreatic cancer	3.5e-05	0.000587	CcSEcCtD
Mitomycin—Cough—Doxorubicin—pancreatic cancer	3.47e-05	0.000582	CcSEcCtD
Mitomycin—Shock—Epirubicin—pancreatic cancer	3.45e-05	0.000579	CcSEcCtD
Mitomycin—Dizziness—Docetaxel—pancreatic cancer	3.44e-05	0.000577	CcSEcCtD
Mitomycin—Thrombocytopenia—Epirubicin—pancreatic cancer	3.44e-05	0.000576	CcSEcCtD
Mitomycin—Hypertension—Doxorubicin—pancreatic cancer	3.44e-05	0.000576	CcSEcCtD
Mitomycin—Discomfort—Doxorubicin—pancreatic cancer	3.35e-05	0.000561	CcSEcCtD
Mitomycin—Anorexia—Epirubicin—pancreatic cancer	3.35e-05	0.000561	CcSEcCtD
Mitomycin—Vomiting—Docetaxel—pancreatic cancer	3.31e-05	0.000555	CcSEcCtD
Mitomycin—Rash—Docetaxel—pancreatic cancer	3.28e-05	0.00055	CcSEcCtD
Mitomycin—Dermatitis—Docetaxel—pancreatic cancer	3.28e-05	0.00055	CcSEcCtD
Mitomycin—Confusional state—Doxorubicin—pancreatic cancer	3.28e-05	0.000549	CcSEcCtD
Mitomycin—Headache—Docetaxel—pancreatic cancer	3.26e-05	0.000547	CcSEcCtD
Mitomycin—Oedema—Doxorubicin—pancreatic cancer	3.25e-05	0.000545	CcSEcCtD
Mitomycin—Shock—Doxorubicin—pancreatic cancer	3.2e-05	0.000536	CcSEcCtD
Mitomycin—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.18e-05	0.000533	CcSEcCtD
Mitomycin—Dyspnoea—Epirubicin—pancreatic cancer	3.13e-05	0.000525	CcSEcCtD
Mitomycin—Somnolence—Epirubicin—pancreatic cancer	3.12e-05	0.000523	CcSEcCtD
Mitomycin—Anorexia—Doxorubicin—pancreatic cancer	3.1e-05	0.000519	CcSEcCtD
Mitomycin—Nausea—Docetaxel—pancreatic cancer	3.09e-05	0.000518	CcSEcCtD
Mitomycin—Decreased appetite—Epirubicin—pancreatic cancer	3.05e-05	0.000512	CcSEcCtD
Mitomycin—Fatigue—Epirubicin—pancreatic cancer	3.03e-05	0.000508	CcSEcCtD
Mitomycin—Pain—Epirubicin—pancreatic cancer	3e-05	0.000503	CcSEcCtD
Mitomycin—Dyspnoea—Doxorubicin—pancreatic cancer	2.9e-05	0.000486	CcSEcCtD
Mitomycin—Feeling abnormal—Epirubicin—pancreatic cancer	2.89e-05	0.000485	CcSEcCtD
Mitomycin—Somnolence—Doxorubicin—pancreatic cancer	2.89e-05	0.000484	CcSEcCtD
Mitomycin—Decreased appetite—Doxorubicin—pancreatic cancer	2.82e-05	0.000474	CcSEcCtD
Mitomycin—Fatigue—Doxorubicin—pancreatic cancer	2.8e-05	0.00047	CcSEcCtD
Mitomycin—Pain—Doxorubicin—pancreatic cancer	2.78e-05	0.000466	CcSEcCtD
Mitomycin—Body temperature increased—Epirubicin—pancreatic cancer	2.78e-05	0.000465	CcSEcCtD
Mitomycin—Feeling abnormal—Doxorubicin—pancreatic cancer	2.68e-05	0.000449	CcSEcCtD
Mitomycin—Body temperature increased—Doxorubicin—pancreatic cancer	2.57e-05	0.000431	CcSEcCtD
Mitomycin—Asthenia—Epirubicin—pancreatic cancer	2.52e-05	0.000422	CcSEcCtD
Mitomycin—Diarrhoea—Epirubicin—pancreatic cancer	2.4e-05	0.000403	CcSEcCtD
Mitomycin—Asthenia—Doxorubicin—pancreatic cancer	2.33e-05	0.000391	CcSEcCtD
Mitomycin—Dizziness—Epirubicin—pancreatic cancer	2.32e-05	0.000389	CcSEcCtD
Mitomycin—Vomiting—Epirubicin—pancreatic cancer	2.23e-05	0.000374	CcSEcCtD
Mitomycin—Diarrhoea—Doxorubicin—pancreatic cancer	2.22e-05	0.000373	CcSEcCtD
Mitomycin—Rash—Epirubicin—pancreatic cancer	2.21e-05	0.000371	CcSEcCtD
Mitomycin—Dermatitis—Epirubicin—pancreatic cancer	2.21e-05	0.000371	CcSEcCtD
Mitomycin—Headache—Epirubicin—pancreatic cancer	2.2e-05	0.000369	CcSEcCtD
Mitomycin—Dizziness—Doxorubicin—pancreatic cancer	2.15e-05	0.00036	CcSEcCtD
Mitomycin—Nausea—Epirubicin—pancreatic cancer	2.09e-05	0.00035	CcSEcCtD
Mitomycin—Vomiting—Doxorubicin—pancreatic cancer	2.07e-05	0.000346	CcSEcCtD
Mitomycin—Rash—Doxorubicin—pancreatic cancer	2.05e-05	0.000343	CcSEcCtD
Mitomycin—Dermatitis—Doxorubicin—pancreatic cancer	2.05e-05	0.000343	CcSEcCtD
Mitomycin—Headache—Doxorubicin—pancreatic cancer	2.03e-05	0.000341	CcSEcCtD
Mitomycin—Nausea—Doxorubicin—pancreatic cancer	1.93e-05	0.000324	CcSEcCtD
